Stanleyson V. Hato

3.4k total citations
29 papers, 2.7k citations indexed

About

Stanleyson V. Hato is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Stanleyson V. Hato has authored 29 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 16 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Stanleyson V. Hato's work include Immunotherapy and Immune Responses (12 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Immune Cell Function and Interaction (10 papers). Stanleyson V. Hato is often cited by papers focused on Immunotherapy and Immune Responses (12 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Immune Cell Function and Interaction (10 papers). Stanleyson V. Hato collaborates with scholars based in Netherlands, United States and Australia. Stanleyson V. Hato's co-authors include W. Joost Lesterhuis, I. Jolanda M. de Vries, Andrea Khong, Frank J. M. van Kuppeveld, Carl G. Figdor, Esdy Rozali, Bruce Robinson, Richard Lake, Joost Schalkwijk and Ruurd Torensma and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Stanleyson V. Hato

29 papers receiving 2.7k citations

Peers

Stanleyson V. Hato
Yong‐Soo Bae South Korea
Na Xiong United States
Rajeev R. Warrier United States
Thomas Soullié Netherlands
Stanleyson V. Hato
Citations per year, relative to Stanleyson V. Hato Stanleyson V. Hato (= 1×) peers Cristina Maria Failla

Countries citing papers authored by Stanleyson V. Hato

Since Specialization
Citations

This map shows the geographic impact of Stanleyson V. Hato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanleyson V. Hato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanleyson V. Hato more than expected).

Fields of papers citing papers by Stanleyson V. Hato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stanleyson V. Hato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanleyson V. Hato. The network helps show where Stanleyson V. Hato may publish in the future.

Co-authorship network of co-authors of Stanleyson V. Hato

This figure shows the co-authorship network connecting the top 25 collaborators of Stanleyson V. Hato. A scholar is included among the top collaborators of Stanleyson V. Hato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stanleyson V. Hato. Stanleyson V. Hato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Horrevorts, Sophie K., Martine Bloemendal, Yumeng Mao, et al.. (2021). Cisplatin inhibits frequency and suppressive activity of monocytic myeloid-derived suppressor cells in cancer patients. OncoImmunology. 10(1). 1935557–1935557. 23 indexed citations
2.
Duffelen, Anne van, Mark A.J. Gorris, Kiek Verrijp, et al.. (2020). The tumour microenvironment shapes dendritic cell plasticity in a human organotypic melanoma culture. Nature Communications. 11(1). 2749–2749. 71 indexed citations
3.
Bakdash, Ghaith, Sonja I. Buschow, Mark A.J. Gorris, et al.. (2016). Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines. Cancer Research. 76(15). 4332–4346. 90 indexed citations
4.
Koning, Coco de, et al.. (2016). Improving cancer immunotherapy by targeting the STATe of MDSCs. OncoImmunology. 5(7). e1196312–e1196312. 46 indexed citations
5.
Wortel, Inge M. N., Tjitske Duiveman‐de Boer, Sonja I. Buschow, et al.. (2016). Human CD1c+ DCs are critical cellular mediators of immune responses induced by immunogenic cell death. OncoImmunology. 5(8). e1192739–e1192739. 82 indexed citations
6.
Tel, Jurjen, Harm Westdorp, Winald R. Gerritsen, et al.. (2016). Preclinical exploration of combining plasmacytoid and myeloid dendritic cell vaccination with BRAF inhibition. Journal of Translational Medicine. 14(1). 88–88. 11 indexed citations
7.
Torensma, Ruurd, et al.. (2015). Cellular immunotherapy in ovarian cancer: Targeting the stem of recurrence. Gynecologic Oncology. 137(2). 335–342. 29 indexed citations
8.
Beek, Jasper J. P. van, Florian Wimmers, Stanleyson V. Hato, I. Jolanda M. de Vries, & Annette E. Sköld. (2014). Dendritic Cell Cross Talk with Innate and Innate-like Effector Cells in Antitumor Immunity: Implications for DC Vaccination. Critical Reviews in Immunology. 34(6). 517–536. 39 indexed citations
9.
Vasaturo, Angela, et al.. (2013). Clinical Implications of Co-Inhibitory Molecule Expression in the Tumor Microenvironment for DC Vaccination: A Game of Stop and Go. Frontiers in Immunology. 4. 417–417. 59 indexed citations
10.
Bogaard, Ellen H. van den, Judith G.M. Bergboer, Ivonne M.J.J. van Vlijmen‐Willems, et al.. (2013). Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis. Journal of Clinical Investigation. 123(2). 917–27. 283 indexed citations
11.
Qian, Feng, Stanleyson V. Hato, Martijn A. Langereis, et al.. (2012). MDA5 Detects the Double-Stranded RNA Replicative Form in Picornavirus-Infected Cells. Cell Reports. 2(5). 1187–1196. 204 indexed citations
12.
Hato, Stanleyson V., I. Jolanda M. de Vries, & W. Joost Lesterhuis. (2012). STATing the importance of immune modulation by platinum chemotherapeutics. OncoImmunology. 1(2). 234–236. 31 indexed citations
13.
Lesterhuis, W. Joost, Cornelis J.A. Punt, Stanleyson V. Hato, et al.. (2011). Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice. Journal of Clinical Investigation. 121(8). 3100–3108. 275 indexed citations
14.
Tel, Jurjen, Stanleyson V. Hato, Ruurd Torensma, et al.. (2011). The chemotherapeutic drug oxaliplatin differentially affects blood DC function dependent on environmental cues. Cancer Immunology Immunotherapy. 61(7). 1101–1111. 42 indexed citations
15.
Kamsteeg, Marijke, Mieke Bergers, Patrick L.J.M. Zeeuwen, et al.. (2011). Type 2 Helper T-Cell Cytokines Induce Morphologic and Molecular Characteristics of Atopic Dermatitis in Human Skin Equivalent. American Journal Of Pathology. 178(5). 2091–2099. 63 indexed citations
16.
Lidsky, Peter V., Lyudmila I. Romanova, Marina S. Kolesnikova, et al.. (2009). Interactions between Viral and Prokaryotic Pathogens in a Mixed Infection with Cardiovirus and Mycoplasma. Journal of Virology. 83(19). 9940–9951. 7 indexed citations
17.
Hato, Stanleyson V., Frédéric Sorgeloos, Céline Ricour, et al.. (2009). Differential IFN-α/β production suppressing capacities of the leader proteins of mengovirus and foot-and-mouth disease virus. Cellular Microbiology. 12(3). 310–317. 18 indexed citations
18.
Ricour, Céline, Sophie Delhaye, Stanleyson V. Hato, et al.. (2008). Inhibition of mRNA export and dimerization of interferon regulatory factor 3 by Theiler's virus leader protein. Journal of General Virology. 90(1). 177–186. 61 indexed citations
19.
Hato, Stanleyson V., Céline Ricour, Barbara M. Schulte, et al.. (2007). The mengovirus leader protein blocks interferon-α/β gene transcription and inhibits activation of interferon regulatory factor 3. Cellular Microbiology. 9(12). 2921–2930. 99 indexed citations
20.
Lidsky, Peter V., Stanleyson V. Hato, Ann C. Palmenberg, et al.. (2006). Nucleocytoplasmic Traffic Disorder Induced by Cardioviruses. Journal of Virology. 80(6). 2705–2717. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026